Industry Category
Business Keywords
Company Description
Juno Therapeutics, Inc. is now a part of Bristol Myers Squibb, a leading biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for patients battling serious diseases. Juno Therapeutics, Inc. contributed significantly to the advancement of cell therapy and immunotherapy within the Bristol Myers Squibb portfolio. The collective focus remains on producing the next generation of medicines to treat cancer and other serious diseases.
The primary address for Juno Therapeutics, Inc., now under Bristol Myers Squibb, is 400 Dexter Ave N., Seattle, WA 98109, US. This location serves as a hub for ongoing research and development efforts aimed at furthering advancements in biotechnology and pharmaceutical solutions.
Juno Therapeutics, Inc.’s legacy continues to drive progress in the field. We encourage the manager of Juno Therapeutics, Inc. to create a customized and exclusive company showcase and product listing on our platform, highlighting the innovations and contributions made under the Bristol Myers Squibb umbrella.
Juno Therapeutics, Inc. fait désormais partie de Bristol Myers Squibb, une société biopharmaceutique de premier plan qui se consacre à la découverte, au développement et à la fourniture de médicaments innovants aux patients luttant contre des maladies graves. Juno Therapeutics, Inc. a contribué de manière significative à l'avancement de la thérapie cellulaire et de l'immunothérapie au sein du portefeuille de Bristol Myers Squibb. L'objectif collectif reste de produire la prochaine génération de médicaments pour traiter le cancer et d'autres maladies graves.
L'adresse principale de Juno Therapeutics, Inc., qui fait maintenant partie de Bristol Myers Squibb, est 400 Dexter Ave N., Seattle, WA 98109, États-Unis. Ce lieu sert de plaque tournante pour les efforts de recherche et de développement en cours visant à faire progresser la biotechnologie et les solutions pharmaceutiques.
L'héritage de Juno Therapeutics, Inc. continue de stimuler les progrès dans le domaine. Nous encourageons le responsable de Juno Therapeutics, Inc. à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, mettant en évidence les innovations et les contributions apportées sous l'égide de Bristol Myers Squibb.
Key Personnel / Employees
Compare Companies Side by Side
Compare Juno Therapeutics, Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
Juno Therapeutics, Inc.Main Company |
Alloy Therapeutics,...View Profile |
Chimeric Therapeutic...View Profile |
Strike Pharma ABView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2017 | 2020 | 2020 |
|
Company Size
|
— | 51-200 | 2-10 | 2-10 |
|
City
|
Seattle, WA | Boston, Massachusetts | Carlton, Victoria | |
|
Country
|
United States | United States | Australia | |
|
Skills & Keywords
Comparing with main company
|
8 Total Skills
Biopharmaceutical
Cell Therapy
Immunotherapy
Oncology
Drug Development
Pharmaceutical Research
Biotechnology
cell therapy
|
12 Total
12 Unique
Unique Skills:
ASO
Biologics Discovery
Biotech
Bispecific Antibodies
Chimeric Antigen Receptors
Company Creation
+6
|
6 Total
1 Common
5 Unique
Match
13%
Common Skills:
Cell Therapy
Unique Skills:
Biotech
Cancer Research
drug development
Immunooncology
Life Sciences
|
4 Total
1 Common
3 Unique
Match
13%
Common Skills:
Drug Development
Unique Skills:
CAR-T
Immuno-oncology
Personalized medicine
|
4
Total Companies2017
Oldest Founded2
Countries27
Unique SkillsSimilar Companies
Other organizations in the same industry
Einsted.Bio
Biotechnology-ResearchAn innovative solution to a global problem: we transform greenhouse gases into clean energy ⚡🌍🌱
Orbit Genomics
Biotechnology-ResearchThe Future of Precision Medicine
Alternative Company Names
This company is also known as